Biographic Information on the Committee on Emergency and Continuous Exposure Guidance Levels for Selected Submarine Contaminants
ERNEST McCONNELL (Chair) is president of ToxPath, Inc., a consulting firm in Raleigh, NC, that specializes in experimental toxicology and pathology. Before becoming a consultant, Dr. McConnell was director of the Division of Toxicological Research and Testing Program of the National Toxicology Program at the National Institute of Environmental Health Sciences. He has served two terms as a member of the National Research Council Committee on Toxicology and on several other committees, including the Subcommittee on Manufactured Vitreous Fibers. He received his DVM from Ohio State University and his MS in pathology from Michigan State University. He completed his residency in comparative pathology at the Armed Forces Institute of Pathology.
RAKESH DIXIT is head of toxicology with MedImmune/AstraZeneca Biologics. Previously he was a senior director of toxicology with Johnson and Johnson and associate director in Safety Assessment for Merck Research Laboratories, where he conducted safety-assessment studies. His research interests include safety and toxicity biomarkers, safety assessment of pharmaceutical agents, biochemical mechanisms of toxicity, and toxicokinetics. He is the editor-in-chief of Toxicology Mechanisms and Methods and associate editor of Toxicology Applied Pharmacology and Journal of Toxicology and Environmental Health and Methods. Dr. Dixit served on the National Research Council Subcommittee on Jet Propulsion Fuel 8 and continues to serve on the Committee on Acute Exposure Guideline Levels. He has over 60 peer reviewed publications and book chapters. He has more than 100 invited presentations in the national and interna-
tional meetings. Dr. Dixit received his PhD in toxicology and biochemistry from University of Lucknow with research work at Case Western Reserve University. He is board-certified in toxicology by the American Board of Toxicology since 1992.
DAVID DORMAN is associate dean for research and graduate studies in the College of Veterinary Medicine at North Carolina State University. The primary objective of his research is to provide a refined understanding of chemically induced neurotoxicity in laboratory animals that will lead to improved assessment of potential neurotoxicity in humans. Dr. Dorman's research interests include evaluation of the effects of neurotoxic chemicals on potentially sensitive subpopulations, examination of chemical-induced effects on behavior and cognitive development, and the application of pharmacokinetic methods to the risk assessment of neurotoxicants. He received his DVM from Colorado State University. He completed a combined PhD and residency program in toxicology at the University of Illinois at Champaign-Urbana and is a diplomate of the American Board of Veterinary Toxicology and the American Board of Toxicology.
MAUREEN FEUSTON is associate vice president for drug-safety evaluation at sanofi-aventis Inc. Before joining sanofi-aventis, she was responsible for general and reproductive toxicology at Mobil Oil Corporation’s Environmental Health and Safety Laboratory. Dr. Feuston has held a number of elected positions in scientific societies, including president of the Middle Atlantic Reproductive and Teratology Association and council member of the Society of Toxicology’s Reproductive and Developmental Specialty Section, and has served on numerous committees in the Teratology Society. She has also served on the National Research Council Subcommittee on Reproductive and Developmental Toxicants. She received her PhD in developmental biology from the University of Cincinnati.
JACK HARKEMA is University Distinguished Professor in the College of Veterinary Medicine at Michigan State University (MSU). He is also the director of the Laboratory for Experimental and Toxicologic Pathology in the National Food Safety and Toxicology Center and the director of the Mobile Air Research Laboratory at MSU. Dr. Harkema's research is designed to understand the cellular and molecular mechanisms involved in the pathogenesis of airway injury caused by the inhalation of airborne pollutants. Dr. Harkema received his DVM from MSU and his PhD in comparative pathology from the University of California, Davis.
HOWARD KIPEN is a professor of environmental and occupational medicine at the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School. His research focuses on controlled-exposure studies of the effects of environmental agents, such as benzene, asbestos, and particulate air
pollutants. He has served as a member or chair of several Institute of Medicine committees, including the Committee on the Persian Gulf Syndrome Comprehensive Clinical Evaluation Program. He received his MD from University of California at San Francisco and his MPH from Columbia University School of Public Health. He is board-certified in internal medicine and occupational medicine.
LOREN KOLLER is an independent consultant and former professor and dean of the College of Veterinary Medicine at Oregon State University. His research interests include toxic, pathologic, and immunologic effects of toxic substances and the effects of environmental contaminants on tumor growth and immunity. He is a former member of the National Research Council Committee on Toxicology and several of its subcommittees, including the Subcommittee on Immunotoxicity and the Subcommittee on Zinc Cadmium Sulfide. He serves on the Institute of Medicine Committee on the Assessment of Health Effects of Vietnam Veterans. He received his DVM from Washington State University and his PhD in pathology from the University of Wisconsin.
JOHN O’DONOGHUE is an adjunct associate professor of environmental medicine at the University of Rochester School of Medicine and Dentistry. He was the director of the Health and Environment Laboratories and vice president for health, safety, and environment at Eastman Kodak Company until his retirement in 2004. His research interests include neurotoxicology and toxicologic pathology. Dr. O'Donoghue has served on several National Research Council committees, including the Committee on Toxicology and the Subcommittee on Toxicological Hazard and Risk Assessment. He received his VMD and PhD from the University of Pennsylvania and is a diplomate of the American Board of Toxicology.
JOYCE TSUJI is a principal scientist in the toxicology and health risk practice of Exponent, Inc. She is a board-certified toxicologist with experience in risk assessment and risk communication on projects in the United States and internationally. Her specific expertise includes exposure assessment, environmental-health education, and biomonitoring for exposure to chemicals in the environment. She serves on the National Research Council Subcommittee on Spacecraft Exposure Guidelines and served on the Subcommittee on Submarine Escape Action Levels and the Subcommittee on Copper in Drinking Water. She received her PhD in physiology and ecology from the Department of Zoology at the University of Washington.
ANNETTA WATSON is a senior research staff scientist in the Life Sciences Division of Oak Ridge National Laboratory. She has been involved in the development of reference doses, acute exposure guideline levels, and other decision criteria for chemical-warfare agents. Dr. Watson has also interpreted and
applied toxicologic information on hazardous materials to meet community emergency preparedness planning and training needs. She has served on numerous National Research Council committees—including the Committee on Toxicology, the Subcommittee on Toxicological Hazard and Risk Assessment, and the Subcommittee on Guidelines for Military Field Drinking Water Quality—and the Institute of Medicine Committee to Survey the Health Effects of Mustard Gas and Lewisite. She received a PhD from the School of Agriculture at the University of Kentucky and an undergraduate degree in entomology from Purdue University.